Reply: Clarification of Data from 1858 C/T Polymorphism of the Protein Tyrosine Phosphatase Nonreceptor 22 Gene and Rheumatoid Arthritis Risk in Europeans: A Meta-analysis

Archives of Medical Research

Volumn 43, Issue 2, 2012, Pages 172-

  Ke Wei, Ren ^a   Yuan Yuan, Mi ^b   Nan Wei, Xu ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE;

DNA POLYMORPHISM; EUROPE; GENETIC ANALYSIS; HUMAN; LETTER; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 84860610155     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.03.004     Document Type: Letter

References (5)

1. Nong L.M., Ren K.W., Xu N.W., et al. 1858 C/T Polymorphism of the protein tyrosine phosphatase nonreceptor 22 gene and rheumatoid arthritis risk in Europeans: a meta-analysis. Arch Med Res 2011, 42:698-702.
2. Simkins H.M., Merriman M.E., Highton J., et al. Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum 2005, 52:2222-2225.
3. van Oene M., Wintle R.F., Liu X., et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005, 52:1993-1998.
4. Harrison P., Pointon J.J., Farrar C., et al. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2006, 45:1009-1011.
5. Handoll H.H. Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 2006, 87:875.